InterCure to Participate in Cowen 5th Annual Cannabis Conference

InterCure Ltd (NASDAQ: INCR) announced CEO Alexander Rabinovitch will participate in the Cowen 5th Annual Cannabis Conference on December 8, 2022.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

InterCure Ltd (NASDAQ: INCR) announced CEO Alexander Rabinovitch will participate in the Cowen 5th Annual Cannabis Conference on December 8, 2022. He will join an industry leaders panel at 9:30 AM EST and conduct one-on-one sessions by appointment. InterCure, operating as Canndoc, stands as Israel's largest licensed cannabis producer, leading the cannabis market outside North America with a high-margin 'seed-to-sale' model.

For more information, visit InterCure's website.

Argus Session date unavailable

-0.85% session move Open Argus

Details

News Market Reaction – INCR

The recorded move for INCR in the trading session of this news was -0.85%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

12/08/2022 - 09:30 AM EST

Mr. Rabinovitch is one of the global cannabis senior executives to participate

NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 08, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Cowen 5^th Annual Cannabis Conference, taking place December 8^th, 2022.

Mr. Rabinovitch will take part in the industry leaders panel on Thursday, December 8^th, 2022 at 9:30 AM EST, and will be available for 1 on 1 sessions by appointment only.

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: http://www.intercure.co.

Contact:

InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@intercure.co

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What event is InterCure's CEO participating in?

InterCure's CEO, Alexander Rabinovitch, will participate in the Cowen 5th Annual Cannabis Conference on December 8, 2022.

When is Alexander Rabinovitch speaking at the conference?

He will speak at the conference on December 8, 2022, at 9:30 AM EST.

What company does Alexander Rabinovitch lead?

He leads InterCure Ltd, which operates as Canndoc.

What is InterCure known for?

InterCure is known as Israel's largest licensed cannabis producer and a leading company in the cannabis market outside of North America.

What is InterCure's business model?

InterCure utilizes a high-margin 'seed-to-sale' vertically integrated model in the cannabis industry.

InterCure to Participate in Cowen 5th Annual Cannabis Conference